U.S., Dec. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07289100) titled 'Novel Sensors and Artificial Intelligence for Detection of Acute Pulmonary Exacerbations in Cystic Fibrosis and Bronchiectasis' on Nov. 17.
Brief Summary: The goal of this observational study is to learn about new sensors that measure changes in the body that happen during a chest infection, such as breathing rate and heart rate. This study will be with adults who have either cystic fibrosis or bronchiectasis who start treatment with intravenous antibiotics (usually for around 2 weeks).
The main question it aims to answer is the change in sensor measure (such as heart rate) between the start and end of treatment for a chest infecti...